How much funding has Proov raised?

Proov has raised $9.7M in total funding, most recently a Series A round.

Who are Proov's investors?

Proov's investors include Hambrecht Ducera Growth Ventures, SteelSky Ventures, Lightship Capital, Mangrove Capital Partners.

Where is Proov headquartered?

Proov is headquartered in United States.

What industry is Proov in?

Proov operates in Femtech, Healthcare.

Proov

Proov Test | Fertility Tests | Hormone Support | Official Site

United States · $9.7M raised

Femtech

Healthcare

Business Model: B2C
Website: proovtest.com
Total Funding: $9.7M

Last Round: $9.7M Series AJul 2021
Rounds: 1

About

Proov makes FDA-cleared at-home hormone and fertility test kits, including the original PdG progesterone test, to help women track ovulation, diagnose hormone imbalances, and navigate fertility struggles or perimenopause. Founded by Dr. Amy Beckley, a PhD scientist who faced her own fertility and hormone challenges, the company pairs its test kits with a companion app and network of physician advisors for full-cycle hormone insight.

Summary

Proov is a Femtech company based in United States. It has raised $9.7M in total across 1 round, most recently a $9.7M Series A round in Jul 2021. Investors include Hambrecht Ducera Growth Ventures, SteelSky Ventures and Lightship Capital.